Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma)
November 25, 2024 07:54 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Smoking Cessation - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 10+...
United States Smoking Cessation Market Analysis 2021: Treatment Options, Pipeline Products, Key Products Marketed, Market Valuations and Forecasts
January 18, 2021 09:48 ET
|
Research and Markets
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "US Smoking Cessation Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. The latest research...
United States Smoking Cessation Market and Competitive Landscape 2020
September 25, 2020 06:59 ET
|
Research and Markets
Dublin, Sept. 25, 2020 (GLOBE NEWSWIRE) -- The "US Smoking Cessation Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. US Smoking Cessation...